Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25701767 | 0.87 | TSHR (0.43) | TSHRKMT2AALDH1A1ESR1HSD17B10 | |
| SCHEMBL9400301 | 0.84 | TSHR (0.55) | TSHRKMT2AALDH1A1ESR1HSD17B10 | |
| SCHEMBL69507 | 0.83 | TSHR (0.33) | TSHRKMT2AALDH1A1ESR1HSD17B10 | |
| SCHEMBL3191892 | 0.83 | TSHR (0.33) | TSHRKMT2AALDH1A1ESR1HSD17B10 | |
| SCHEMBL1053833 | 0.83 | GAA (0.44) | TSHRKMT2AALDH1A1ESR1HSD17B10 | |
| SCHEMBL7795589 | 0.83 | ALDH1A1 (0.42) | TSHRKMT2AALDH1A1ESR1HSD17B10 | |
| SCHEMBL25701766 | 0.81 | TSHR (0.35) | TSHRKMT2AALDH1A1ESR1HSD17B10 | |
| SCHEMBL1685817 | 0.81 | TSHR (0.33) | TSHRKMT2AALDH1A1ESR1HSD17B10 | |
| SCHEMBL8850033 | 0.81 | TSHR (0.33) | TSHRKMT2AALDH1A1ESR1HSD17B10 | |
| Ethylene SCHEMBL11193217 | 0.81 | TSHR (0.33) | TSHRKMT2AALDH1A1ESR1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0389420-B1 | Ethylenically unsaturated compounds containing 1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidine moieties, and polymers, copolymers and stabilized compositions | CIBA GEIGY AG (CH) | 1994-09-21 | — | — | EP | claimed |
| US-5047489-A | Ethylenically unsaturated compounds containing 1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidine moieties, and polymers, copolymers and stabilized compositions | CIBA-GEIGY CORPORATION (US) | 1991-09-10 | — | — | US | claimed |
| US-4983737-A | LIGHT STABILIZERS FOR POLYMERIC SUBSTRATES | CIBA-GEIGY CORPORATION (US) | 1991-01-08 | — | — | US | claimed |
| EP-0389420-A1 | Ethylenically unsaturated compounds containing 1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidine moieties, and polymers, copolymers and stabilized compositions | CIBA-GEIGY AG (CH) | 1990-09-26 | — | — | EP | claimed |
| US-20240002563-A1 | CURABLE POLYMER COMPOSITION | Kraton Corporation (US) | 2024-01-04 | — | — | US | disclosed |
| EP-4299645-A1 | CURABLE POLYMER COMPOSITION | Kraton Polymers Nederland B.V. (NL) | 2024-01-03 | — | — | EP | disclosed |
| US-11248114-B2 | Modified heterophasic polyolefin composition | MILLIKEN & COMPANY (US) | 2022-02-15 | — | — | US | disclosed |
| WO-2017166762-A1 | CROSSLINKABLE POLYMERIC COMPOSITIONS WITH METHYL-RADICAL SCAVENGERS AND ARTICLES MADE THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-10-05 | — | — | WO | disclosed |
| WO-2017166105-A1 | CROSSLINKABLE POLYMERIC COMPOSITIONS WITH METHYL-RADICAL SCAVENGERS AND ARTICLES MADE THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-10-05 | — | — | WO | disclosed |
| US-20130059952-A1 | PHOSPHO-SUBSTITUTED ALKOXYAMINE COMPOUNDS | BASF SE (DE) | 2013-03-07 | — | — | US | disclosed |
| US-20130059952-A1 | PHOSPHO-SUBSTITUTED ALKOXYAMINE COMPOUNDS | BASF SE (DE) | 2013-03-07 | — | — | US | disclosed |
| WO-2011086114-A1 | PHOSPHO-SUBSTITUTED ALKOXYAMINE COMPOUNDS | BASF SE (DE) | 2011-07-21 | — | — | WO | disclosed |
| EP-0389422-B1 | Stabilizers derived from N-hydroxy hindered amines by Michael addition reactions | CIBA GEIGY AG (CH) | 1994-09-21 | — | — | EP | disclosed |
| EP-0389420-B1 | Ethylenically unsaturated compounds containing 1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidine moieties, and polymers, copolymers and stabilized compositions | CIBA GEIGY AG (CH) | 1994-09-21 | — | — | EP | disclosed |
| US-5077340-A | Ethylenically unsaturated compounds containing 1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidine moieties, and polymers, copolymers and stabilized compositions | CIBA-GEIGY CORPORATION (US) | 1991-12-31 | — | — | US | disclosed |
| US-5047489-A | Ethylenically unsaturated compounds containing 1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidine moieties, and polymers, copolymers and stabilized compositions | CIBA-GEIGY CORPORATION (US) | 1991-09-10 | — | — | US | disclosed |
| US-5015678-A | Light stabilized polymers by the addition of N-hydoxyamines | CIBA-GEIGY CORPORATION (US) | 1991-05-14 | — | — | US | disclosed |
| US-4983737-A | LIGHT STABILIZERS FOR POLYMERIC SUBSTRATES | CIBA-GEIGY CORPORATION (US) | 1991-01-08 | — | — | US | disclosed |
| EP-0389422-A2 | Stabilizers derived from N-hydroxy hindered amines by Michael addition reactions | CIBA-GEIGY AG (CH) | 1990-09-26 | — | — | EP | disclosed |
| EP-0389420-A1 | Ethylenically unsaturated compounds containing 1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidine moieties, and polymers, copolymers and stabilized compositions | CIBA-GEIGY AG (CH) | 1990-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130059952-A1 | PHOSPHO-SUBSTITUTED ALKOXYAMINE COMPOUNDS | PFAS, PHOSPHO1, PIK3CA | TSHR 2762/4885KMT2A 800/4885ALDH1A1 2401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.